{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:48:50Z","timestamp":1773211730010,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mjt.0b013e3181ff7c79","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T17:28:41Z","timestamp":1293816521000},"page":"57-60","source":"Crossref","is-referenced-by-count":7,"title":["Statin-Associated Rhabdomyolysis With Acute Renal Failure Complicated by Intradialytic NSTEMI"],"prefix":"10.1097","volume":"20","author":[{"given":"Subrata","family":"Kar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Chockalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210202","doi-asserted-by":"crossref","first-page":"949","DOI":"10.7326\/0003-4819-142-11-200506070-00020","article-title":". Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.","volume":"142","author":"Ireland","year":"2005","journal-title":"Ann Int Med"},{"key":"R2-10-20210202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury.","volume":"361","author":"Bosch","year":"2009","journal-title":"New Eng J Med"},{"key":"R3-10-20210202","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy.","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00228-009-0723-7","article-title":". Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.","volume":"65","author":"Wu","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"R5-10-20210202","doi-asserted-by":"crossref","first-page":"c95","DOI":"10.1016\/j.amjcard.2005.12.016","article-title":"Benefit versus risk in statin treatment.","volume":"97","author":"Guyton","year":"2006","journal-title":"Am J Cardiol"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjcard.2005.12.005","article-title":"Statins, cardiovascular disease, and drug safety.","volume":"97","author":"Gotto","year":"2006","journal-title":"Am J Cardiol"},{"key":"R7-10-20210202","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0022-5223(98)70177-1","article-title":"Rhabdomyolysis after coronary artery bypass grafting in a patient receiving simvastatin.","volume":"116","author":"Alvarez","year":"1998","journal-title":"Thorac Cardiovasc Surg"},{"key":"R8-10-20210202","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1016\/j.amjcard.2005.06.007","article-title":"Pharmacological options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.","volume":"96","author":"McKenney","year":"2005","journal-title":"Am J Cardiol"},{"issue":"Suppl 2","key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ajhp\/60.suppl_2.S1","article-title":"Niacin in the treatment of dyslipidemia: insight from adult treatment panel III introduction.","volume":"60","author":"Talbert","year":"2003","journal-title":"Am J Health-Syst Pharm"},{"issue":"Suppl 2","key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ajhp\/60.suppl_2.S15","article-title":"Advances in the understanding and management of dyslipidemia: using niacin-based therapies.","volume":"60","author":"Ito","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"R11-10-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MOL.0b013e32832d3b9d","article-title":"Nicotinic acid and the prevention of coronary artery disease.","volume":"20","author":"Digby","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.smj.0000208120.73327.db","article-title":"Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.","volume":"99","author":"Insull","year":"2006","journal-title":"South Med J"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"i39","DOI":"10.1016\/j.amjcard.2005.12.026","article-title":"Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.","volume":"98","author":"Robinson","year":"2006","journal-title":"Am J Cardiol"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1016\/j.amjcard.2005.12.029","article-title":"Clinical overview of omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.","volume":"98","author":"Bays","year":"2006","journal-title":"Am J Cardiol"},{"key":"R15-10-20210202","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1016\/j.amjcard.2005.12.022","article-title":"Dietary omega-3 fatty acid intake and cardiovascular risk.","volume":"98","author":"Psota","year":"2006","journal-title":"Am J Cardiol"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"i61","DOI":"10.1016\/j.amjcard.2005.12.028","article-title":"Secondary prevention of coronary artery disease with omega-3 fatty acids.","volume":"98","author":"Jacobson","year":"2006","journal-title":"Am J Cardiol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-201301000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:42:01Z","timestamp":1618036921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201301000-00010"}},"subtitle":["A Review of Lipid Management Considerations"],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181ff7c79","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}